




Searching News Database: Glivec
HSMN NewsFeed - 11 Jul 2017
Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team
Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team
HSMN NewsFeed - 13 Mar 2017
Lycera Announces the Appointment of Pablo J. Cagnoni, M.D., to the Board of Directors
Lycera Announces the Appointment of Pablo J. Cagnoni, M.D., to the Board of Directors
HSMN NewsFeed - 3 Nov 2011
Viamet Pharmaceuticals Appoints Former Novartis Executive Marc Rudoltz, M.D. as Chief Medical Officer
Viamet Pharmaceuticals Appoints Former Novartis Executive Marc Rudoltz, M.D. as Chief Medical Officer
HSMN NewsFeed - 4 Jun 2010
New Data at ASCO Show Novartis Drug Tasigna(R) Surpasses Gleevec(R) for Newly Diagnosed CML Patients
New Data at ASCO Show Novartis Drug Tasigna(R) Surpasses Gleevec(R) for Newly Diagnosed CML Patients
HSMN NewsFeed - 19 Oct 2006
Gleevec(R) Approved in the US for Five Rare Life-Threatening Disorders With Limited Treatment Options
Gleevec(R) Approved in the US for Five Rare Life-Threatening Disorders With Limited Treatment Options
HSMN NewsFeed - 10 Apr 2006
Novartis completes submissions in US and Europe for Gleevec(R) as treatment for four rare types of cancer
Novartis completes submissions in US and Europe for Gleevec(R) as treatment for four rare types of cancer
Additional items found! 8

Members Archive contains
8 additional stories matching:
Glivec
(Password required)
Glivec
(Password required)